InflaRx (IFRX) Return on Equity Growth (1y) (2018 - 2026)
InflaRx (IFRX) Return on Equity Growth (1y) (2018 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
ROE Growth (1y) (Qtr) |
| 1 |
Alterity Therapeutics |
723,416.35 Bn |
723,416.32 Bn |
- |
- |
| 2 |
Belite Bio |
57,340.00 Bn |
57,340.00 Bn |
- |
105.00 |
| 3 |
Quantum Biopharma |
19,125.08 Bn |
19,125.08 Bn |
- |
-3.00 |
| 4 |
Legend Biotech |
3,262.00 Bn |
3,261.71 Bn |
242.10 Mn |
0.00 |
| 5 |
Akari Therapeutics |
1,789.67 Bn |
1,789.67 Bn |
- |
-1.00 |
| 6 |
Evaxion A |
1,480.39 Bn |
1,480.37 Bn |
- |
- |
| 7 |
Psyence Biomedical |
241.78 Bn |
241.78 Bn |
- |
- |
| 8 |
Vertex Pharmaceuticals |
113.54 Bn |
106.29 Bn |
2.59 Bn |
0.00 |
| 9 |
Abivax |
94.26 Bn |
94.26 Bn |
- |
10.00 |
| 10 |
InflaRx |
764.68 Mn |
764.68 Mn |
10,877.40 |
46,922.00 |
| Date | Value |
|---|
| Mar 31, 2026 |
46,922.00 |
| Dec 31, 2025 |
42,366.00 |
| Sep 30, 2025 |
1.00 |
| Jun 30, 2025 |
1.00 |
| Mar 31, 2025 |
0.00 |
| Dec 31, 2024 |
-4,149.00 |
| Sep 30, 2024 |
-3,751.00 |
| Jun 30, 2024 |
-6,396.00 |
| Mar 31, 2024 |
-8,067.00 |
| Dec 31, 2023 |
1,961.00 |
| Sep 30, 2023 |
293.00 |
| Jun 30, 2023 |
4,973.00 |
| Mar 31, 2023 |
6,716.00 |
| Dec 31, 2022 |
991.00 |
| Sep 30, 2022 |
-219,985.00 |
| Jun 30, 2022 |
-199,699.00 |
| Mar 31, 2022 |
-243,053.00 |
| Dec 31, 2021 |
-320,776.00 |
| Sep 30, 2021 |
192,547.00 |
| Jun 30, 2021 |
171,289.00 |
